Financial Statements

Bayer Group Consolidated Income Statements

			[Table 4.1]
	Note	2009	2010
		€ million	€ million
Net sales	[7]	31,168	35,088
Cost of goods sold		(15,135)	(17,103)
Gross profit		16,033	17,985

Selling expenses	[8]	(7,923)	(8,803)
Research and development expenses	[9]	(2,746)	(3,053)
General administration expenses		(1,623)	(1,647)
Other operating income	[10]	922	714
Other operating expenses	[11]	(1,657)	(2,466)
Operating result [EBIT]		3,006	2,730

Equity-method loss	[13.1]	(48)	(56)
Non-operating income		789	384
Non-operating expenses		(1,877)	(1,337)
Non-operating result	[13]	(1,136)	(1,009)

Income before income taxes		1,870	1,721

Income taxes	[14]	(511)	(411)

Income after taxes		1,359	1,310
of which attributable to non-controlling interest	[15]	-	9
of which attributable to Bayer AG stockholders (net income)		1,359	1,301

		€	€
Earnings per share	[16]
Basic*		1.70	1.57
Diluted*		1.70	1.57
* The ordinary shares that resulted from conversion of the mandatory convertible bond were treated as already issued shares since the issuance of the bond.

Last updated: February 28, 2011